| Christopher P Sullivan, MD | |
|
75 Arch St, Suite 301, Akron, OH 44304-1429 | |
| (330) 253-1899 | |
| (330) 253-2108 |
| Full Name | Christopher P Sullivan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 75 Arch St, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477501476 | NPI | - | NPPES |
| 0743904 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 3544533 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher P Sullivan, MD 75 Arch St, Suite 301, Akron, OH 44304-1429 Ph: (330) 253-1899 | Christopher P Sullivan, MD 75 Arch St, Suite 301, Akron, OH 44304-1429 Ph: (330) 253-1899 |
News Archive
Not only that; we have also been awarded the Queen's Award for Enterprise: International Trade in recognition of our outstanding international growth. Meaning we are one of only a handful of businesses who have won multiple awards this year.
AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company's transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.
The New York Times reports on strict stand by Florida governor to avoid HHS money. Meanwhile, other news outlets look at funding for insurance co-ops, efforts to set up health exchanges, and reviews of insurance premium increases.
Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.
The study included 52 patients. The patient's MR images were reviewed by two radiologists, and their diagnosis was compared to the data that was provided by the CAD system.
› Verified 8 days ago
Dr. Michael A Pelini, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Ste 300, Akron, OH 44304 Phone: 330-376-7000 Fax: 330-376-1066 | |
David P. Lang, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #200c, Akron, OH 44333 Phone: 330-665-8031 Fax: 330-665-8360 | |
Ms. Tiffany Mccann, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3561 | |
Jonathan Buggey, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St Ste 300, Akron, OH 44304 Phone: 724-422-6808 | |
Shamsa Baaj, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Mira Rohit Patel, DO Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 161 N Forge St Ste 198, Akron, OH 44304 Phone: 330-375-3039 | |
Richard J Streck, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, 5th Floor Ambulatory Care Center, Akron, OH 44307 Phone: 330-344-6015 Fax: 330-344-6820 |